JPH04318001A - Processed starch excellent in bindability and disintegrability - Google Patents

Processed starch excellent in bindability and disintegrability

Info

Publication number
JPH04318001A
JPH04318001A JP8542691A JP8542691A JPH04318001A JP H04318001 A JPH04318001 A JP H04318001A JP 8542691 A JP8542691 A JP 8542691A JP 8542691 A JP8542691 A JP 8542691A JP H04318001 A JPH04318001 A JP H04318001A
Authority
JP
Japan
Prior art keywords
starch
physical properties
processed
processed starch
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8542691A
Other languages
Japanese (ja)
Other versions
JP3004758B2 (en
Inventor
Etsuo Kamata
悦雄 鎌田
Sueo Nagatomo
末男 長友
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP3085426A priority Critical patent/JP3004758B2/en
Publication of JPH04318001A publication Critical patent/JPH04318001A/en
Application granted granted Critical
Publication of JP3004758B2 publication Critical patent/JP3004758B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To provide a specified processed starch and a pharmaceutical preparation composition prepared therefrom. CONSTITUTION:The objective processed starch excellent in both bindability and disintegrability can be obtained by heating treatment of raw starch in the presence of moisture. The present starch is 8-15wt.% in water content, <10wt.% in cold water solubles and 5-15ml/g in swollen volume. The objective pharmaceutical preparation composition can be obtained by formulation of the present processed starch followed by direct tableting or dry granulation. In contrast to the conventional processed starch, the present starch has a combined function of bindability and disintegrability; therefore, the pharmaceutical preparation of the present invention is high in hardness with promoted disintegration, leading to facilitating its quality design.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は、医薬品に利用される結
合性、崩壊性に優れた加工澱粉、および該加工澱粉を含
有する製剤組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a processed starch with excellent binding and disintegrating properties used in pharmaceuticals, and a pharmaceutical composition containing the processed starch.

【0002】0002

【従来の技術】結合性、崩壊性、増量作用を持った医薬
品添加剤として、澱粉類は、入手の容易さ、天然物であ
り昔から使用されてきたことによる安心感などから、汎
用されてきた。澱粉類は、生澱粉、物理的に変性させた
加工澱粉、化学的に変性させた化工澱粉の3種に分かれ
る。このなかでも加工澱粉は、糊化の程度を変えること
によって、いろいろな物理化学的な性質が発現すること
、低価格であること、化学的には全く生澱粉と同じため
、薬物との反応性がほとんどないこと、などから汎用さ
れている。生澱粉を水に懸濁させ、沸騰するまで加熱し
て澱粉糊とし、湿式造粒用の結合剤として使用すること
は、最も古くからの加工澱粉の利用と言えるが、それ以
外にも種々の加工澱粉が提案されている。
[Prior Art] Starches have been widely used as pharmaceutical excipients with binding, disintegrating, and bulking effects due to their ease of availability and the sense of security that comes from the fact that they are natural products and have been used for a long time. Ta. Starches are divided into three types: raw starch, physically modified starch, and chemically modified modified starch. Among these, modified starch has various physicochemical properties that can be expressed by changing the degree of gelatinization, is low in price, and is chemically the same as raw starch, so it has a high reactivity with drugs. It is widely used because there are almost no Suspending raw starch in water and heating it until it boils to make starch paste, which is used as a binder for wet granulation, is the oldest use of modified starch, but there are many other uses as well. Modified starches have been proposed.

【0003】特公昭46−21471号公報に記載の加
工澱粉は、生澱粉を約20〜50重量%の水分含量とし
、差動ロール製粉機などで、20〜50℃の温度でコン
パクト化、乾燥、粉砕することにより得られるもので、
約4〜40重量%の範囲で冷水に溶解性を示し、その乾
燥物質の膨潤力は約2.5〜12を基準とし、自由密度
は約0.5〜0.7g/mlであり、水分は総重量に対
して約9〜16%である。
[0003] The processed starch described in Japanese Patent Publication No. 46-21471 is obtained by compacting and drying raw starch with a moisture content of about 20 to 50% by weight using a differential roll mill or the like at a temperature of 20 to 50°C. , obtained by crushing
It is soluble in cold water in the range of about 4-40% by weight, its dry substance swelling power is based on about 2.5-12, the free density is about 0.5-0.7 g/ml, and the water is about 9-16% based on the total weight.

【0004】特公昭59−47600号公報に記載の加
工澱粉は、生澱粉をスラリー状とし、50℃以上であっ
て、かつ糊化開始温度を約10℃上回る温度以下で加熱
することで、生澱粉の外殻薄膜構造を破壊することなく
膨潤させ、次いで乾燥することによって得られるもので
あって、その嵩密度が0.25g/cc以上、冷水可溶
分が10重量%未満、膨潤容積が約3〜15ml/g、
保水力が約2以上である。
[0004] The processed starch described in Japanese Patent Publication No. 59-47600 is made by turning raw starch into a slurry and heating it at a temperature of 50°C or higher and about 10°C higher than the gelatinization initiation temperature. It is obtained by swelling the outer thin film structure of starch without destroying it and then drying it, and the bulk density is 0.25 g/cc or more, the cold water soluble content is less than 10% by weight, and the swelling volume is Approximately 3-15ml/g,
Water retention capacity is about 2 or more.

【0005】特開昭58−32828号公報に記載の加
工澱粉は、生澱粉を糊化、冷却、次いで乾燥することに
より得られるものであって、膨潤度が3.0〜6.0で
ある。特開昭60−233019号公報に記載の加工澱
粉は、糊化温度以下の温度で、澱粉を酸、アルカリ、及
び(または)α−アミラーゼ酵素で処理して得た冷水溶
性粒状澱粉より導かれるものである。
[0005] The processed starch described in JP-A-58-32828 is obtained by gelatinizing raw starch, cooling it, and then drying it, and has a degree of swelling of 3.0 to 6.0. . The modified starch described in JP-A-60-233019 is derived from cold water-soluble granular starch obtained by treating starch with acid, alkali, and/or α-amylase enzyme at a temperature below the gelatinization temperature. It is something.

【0006】また、市販品としてスターチ1500(日
本カラコン(株)製)、PCS(旭化成工業(株)製)
といった部分アルファー化澱粉がある。
[0006] Also, commercially available products include Starch 1500 (manufactured by Nippon Colorcon Co., Ltd.) and PCS (manufactured by Asahi Kasei Industries, Ltd.).
There are partially pregelatinized starches such as

【0007】[0007]

【発明が解決しようとする課題】しかし、特公昭46−
21471号公報に記載の加工澱粉は、直接打錠法によ
り錠剤に成形する際の結合性には優れているが、錠剤を
水中で崩壊する力に乏しかった。また、特公昭59−4
7600号公報、特開昭58−32828号公報に記載
の加工澱粉は、錠剤、顆粒剤、カプセル剤に配合した場
合の崩壊性には優れているが、直接打錠法に用いた場合
の結合性に乏しいため、多量に配合することができず、
また、他の結合剤を併用する必要があった。また、特開
昭60−233019号公報に記載の加工澱粉は、直接
圧縮法または乾式顆粒圧縮法に使用される錠剤用結合剤
として有効であるが、錠剤の崩壊性、特に高成形圧で製
錠した場合の錠剤の崩壊性を損なうと言う欠点があった
。また、市販品について述べると、スターチ1500は
、直接打錠法に用いると結合性を示すが、錠剤の崩壊時
間が遅延するという欠点があった。また、PCSは、錠
剤、顆粒剤に配合すると、加工澱粉として最も優れた崩
壊性を示すが、直接打錠用の結合剤としての機能はほと
んどなかった。
[Problem to be solved by the invention] However,
The modified starch described in Japanese Patent No. 21471 has excellent binding properties when formed into tablets by direct compression, but lacks the ability to disintegrate tablets in water. In addition, special public service 59-4
The modified starches described in JP-A No. 7600 and JP-A No. 58-32828 have excellent disintegration properties when incorporated into tablets, granules, and capsules, but have poor binding properties when used in direct tabletting methods. Due to its poor properties, it cannot be added in large quantities.
In addition, it was necessary to use other binders in combination. In addition, the modified starch described in JP-A No. 60-233019 is effective as a binder for tablets used in direct compression method or dry granule compression method, but the disintegration properties of tablets are affected, especially when manufactured under high compression pressure. This had the disadvantage of impairing the disintegration of tablets when they were made into tablets. Regarding commercially available products, Starch 1500 exhibits binding properties when used in the direct compression method, but has the drawback of slowing down the tablet disintegration time. Furthermore, when PCS is incorporated into tablets and granules, it exhibits the best disintegration properties among processed starches, but it has almost no function as a binder for direct tablet compression.

【0008】以上のように、これまでの加工澱粉では、
直接打錠法または乾式顆粒法に用いたときに、結合性と
崩壊性の機能を同時に満足するものはなく、両機能を併
せ持つ加工澱粉が望まれていた。
[0008] As mentioned above, conventionally processed starch
When used in the direct compression method or dry granulation method, there is no starch that satisfies the functions of binding and disintegrating properties at the same time, and a modified starch that has both functions has been desired.

【0009】[0009]

【問題点を解決するための手段、作用】本発明者は、鋭
意検討の結果、生澱粉を水分の存在下、加熱処理するこ
とにより得られる、含水率が8〜15%、冷水可溶分が
10%未満、膨潤容積が5〜15ml/gである加工澱
粉が、直接打錠法または乾式顆粒圧縮法に用いたときに
、結合性、崩壊性の両機能を併せ持つことを見いだし、
本発明に至った。
[Means and effects for solving the problem] As a result of intensive studies, the present inventor has discovered that raw starch is obtained by heating raw starch in the presence of water, has a water content of 8 to 15%, and has a cold water soluble content. It has been found that a modified starch with a swelling volume of less than 10% and a swelling volume of 5 to 15 ml/g has both binding and disintegrating functions when used in a direct compression method or a dry granule compression method,
This led to the present invention.

【0010】即ち、本発明は、生澱粉を水分の存在下、
加熱処理することにより得られる加工澱粉であって、含
水率が8〜15%、冷水可溶分が10%未満、膨潤容積
が5〜15ml/gである結合性、崩壊性に優れる加工
澱粉、および該加工澱粉を含有する製剤組成物に関する
。本発明の加工澱粉は、特定された含水率、冷水可溶分
、膨潤容積を持ち、結合性に優れるので、直接打錠法あ
るいは乾式顆粒圧縮法を用いて粉体あるいは顆粒を錠剤
へ圧縮する場合に、硬度の高い錠剤を得ることができる
。また、乾式顆粒法を用いて顆粒を作ると、粉化の小さ
い、強度の高い顆粒ができる。また、同時に崩壊性にも
優れるので、該加工澱粉を含有した製剤を体内に投与し
たときに、加工澱粉が水を吸水して膨潤するため、製剤
は迅速な崩壊を示し、薬物は速やかに溶出する。また他
の結晶セルロース、乳糖などの結合剤と比べると、崩壊
性がよいことはもちろん薬物に対する安定性が高いこと
、結合性・崩壊性の両機能を持つので処方を簡潔にでき
ることなどにより品質設計が容易になる利点がある。
[0010] That is, the present invention provides raw starch in the presence of water.
A modified starch obtained by heat treatment, which has a water content of 8 to 15%, a cold water soluble content of less than 10%, and a swelling volume of 5 to 15 ml/g, which has excellent binding properties and disintegration properties. and a pharmaceutical composition containing the processed starch. The processed starch of the present invention has a specified water content, cold water soluble content, swelling volume, and excellent binding properties, so the powder or granules can be compressed into tablets using a direct compression method or a dry granule compression method. In some cases, tablets with high hardness can be obtained. In addition, when granules are made using a dry granulation method, granules with high strength and less pulverization can be produced. At the same time, it also has excellent disintegration properties, so when a preparation containing the processed starch is administered into the body, the processed starch absorbs water and swells, resulting in rapid disintegration and drug elution. do. In addition, compared to other binders such as crystalline cellulose and lactose, it has good disintegration properties, has high stability against drugs, and has both binding and disintegration functions, making formulations simple. This has the advantage of making it easier.

【0011】以下本発明について詳細に説明する。本発
明でいう加工澱粉は、生澱粉を水分の存在下、加熱処理
することにより得られるものであって、含水率が8〜1
5%、好ましくは10〜15%、冷水可溶分が10%未
満、好ましくは5%未満、膨潤容積が5〜15ml/g
、好ましくは5〜11ml/gであることが必要である
。また好ましくは、その嵩密度は0.35〜0.65g
/ml、特に好ましくは0.4〜0.6g/ml、10
0メッシュ(目開き150μm)留分が50%以下、特
に好ましくは30%以下である。
The present invention will be explained in detail below. The processed starch referred to in the present invention is obtained by heat-treating raw starch in the presence of moisture, and has a moisture content of 8 to 1.
5%, preferably 10-15%, cold water soluble content less than 10%, preferably less than 5%, swelling volume 5-15 ml/g
, preferably 5 to 11 ml/g. Also preferably, the bulk density is 0.35 to 0.65 g
/ml, particularly preferably 0.4-0.6g/ml, 10
The 0 mesh (opening 150 μm) fraction is 50% or less, particularly preferably 30% or less.

【0012】ここでいう加工澱粉とは、水分の存在下で
加熱処理し、乾燥することにより得られるものであって
、化学的変性を施したものは含まない。また、本発明の
加工澱粉を水中に投入して顕微鏡で観察するとき、ほと
んどの粒子が、膨潤してはいるものの澱粉の粒子形態は
維持されており、個々の粒子は識別可能である。個々の
粒子が識別できないほど破壊された非複屈折性の澱粉で
は、冷水可溶分が増し、後述のように好ましくない。 また偏光顕微鏡で観察すると、非複屈折性を示す粒子の
ほうが複屈折性を示す粒子より多く存在する。
[0012] The term "modified starch" as used herein refers to starch obtained by heat treatment in the presence of moisture and drying, and does not include starch that has been chemically modified. Further, when the processed starch of the present invention is placed in water and observed under a microscope, most of the particles, although swollen, maintain their starch particle morphology, and individual particles can be identified. Non-birefringent starch in which the individual particles are destroyed to the extent that they cannot be identified increases the cold water soluble content, which is undesirable as described below. Furthermore, when observed with a polarizing microscope, there are more particles exhibiting non-birefringence than particles exhibiting birefringence.

【0013】加工澱粉の含水率が8%以下では、澱粉の
可塑性が小さくなると同時に、圧縮した後の弾性回復が
大きくなるために、結合性が小さくなる。含水率が15
%以上では、澱粉の可塑性は大きくなるのだが、圧縮に
より粒子内に含まれる水分が、粒子表面ににじみ出すた
めか、逆に結合性は小さくなるので好ましくない。好ま
しくは10〜15%である。冷水可溶分が10%以上の
加工澱粉では、吸水して溶解する成分が多いため、錠剤
に用いた場合、崩壊液に溶解し粘着性となるため、錠剤
内部への液の浸透が遅くなるので、崩壊が遅延し好まし
くない。好ましくは7%未満である。膨潤容積が5ml
/g未満では、吸水による膨潤が小さいため、錠剤を崩
壊するのに十分な力を与えられない。膨潤容積が15m
l/g以上の加工澱粉を製造するには、糊化の程度を高
くする必要があり、同時に冷水可溶分も増加してしまう
ので、上限は15ml/gである。好ましくは5〜11
ml/gである。
[0013] When the water content of the processed starch is 8% or less, the plasticity of the starch decreases and, at the same time, the elastic recovery after compression increases, resulting in a decrease in binding properties. Moisture content is 15
% or more, the plasticity of the starch increases, but it is not preferable because the moisture contained in the particles oozes out onto the particle surface due to compression, and conversely the binding property decreases. Preferably it is 10-15%. Modified starch with a cold water soluble content of 10% or more has many components that absorb water and dissolve, so when used in tablets, it dissolves in the disintegration liquid and becomes sticky, slowing down the penetration of liquid into the inside of the tablet. Therefore, the disintegration is delayed, which is undesirable. Preferably it is less than 7%. Swelling volume is 5ml
If the amount is less than /g, swelling due to water absorption is small, and therefore sufficient force cannot be applied to disintegrate the tablet. Swelling volume is 15m
In order to produce processed starch of 1/g or more, it is necessary to increase the degree of gelatinization, and at the same time, the cold water soluble content also increases, so the upper limit is 15 ml/g. Preferably 5-11
ml/g.

【0014】また、加工澱粉の嵩密度が0.35ml/
g以下では軽質になるため、粉体としての流動性が悪く
なる。また、圧縮した後の錠剤が厚くなるという欠点が
ある。嵩密度が0.65g/ml以上では、圧縮時の変
形能が小さくなるため、結合性が小さくなり好ましくな
い。特に好ましくは、0.40〜0.60g/mlであ
る。加工澱粉の100メッシュ留分が50%以上と粒度
が大きいと、製剤間の加工澱粉の含量のばらつきが大き
くなるため、錠剤硬度、崩壊時間のばらつきが大きくな
る。また、錠剤がブロック型の崩壊を示すため、薬物の
溶出が遅くなり好ましくない。特に好ましくは、30%
以下である。
[0014] Also, the bulk density of the processed starch is 0.35ml/
If it is less than g, the powder becomes light and has poor fluidity as a powder. Another drawback is that the tablets become thicker after compression. If the bulk density is 0.65 g/ml or more, the deformability during compression will be low, resulting in low bonding properties, which is not preferable. Particularly preferably, it is 0.40 to 0.60 g/ml. When the particle size of the processed starch is large, with a 100 mesh fraction of 50% or more, the content of processed starch varies widely between formulations, resulting in large variations in tablet hardness and disintegration time. In addition, since the tablet shows block-like disintegration, the dissolution of the drug is delayed, which is undesirable. Particularly preferably 30%
It is as follows.

【0015】本発明の加工澱粉の製造方法について述べ
る。本製造方法は、生澱粉を水分の存在下加熱処理する
ことにより、粒子形態を破壊することなく、澱粉粒子を
膨潤させ、次いで乾燥し、必要ならば粉砕することから
なる方法である。加熱時の生澱粉の含水率は、生澱粉乾
燥重量に対して約50%以上であればよいが、生澱粉の
糊化に要する温度は、澱粉が湿潤した程度の含水率では
、含まれる水分が少ないほど高温となるので、含水率が
100%以上であって、ペースト状あるいはスラリー状
を呈する状態で加熱処理するほうがエネルギーコスト的
に有利であり好ましい。また、この状態で加熱したほう
が、全ての粒子に対して均一な加熱ができるので好まし
い。また、加熱温度については、糊化開始温度が澱粉種
、粒径、産地、精製条件、生澱粉の含水率などにより変
化するので特定は困難であるが、ペースト状あるいはス
ラリー状においては、澱粉種に特有の糊化開始温度を1
0℃上回る温度以下の温度で処理すると良い。ちなみに
「澱粉科学ハンドブック」(二国二郎監修、朝倉書店、
1977、p36)によれば、フォトペースト法による
主な澱粉の糊化開始温度は、トウモロコシ;66.8℃
、馬鈴薯;61.0℃、タピオカ;65.4℃、甘藷;
65.8℃である。
The method for producing processed starch of the present invention will be described. This production method consists of heating raw starch in the presence of moisture to swell the starch particles without destroying the particle morphology, followed by drying and, if necessary, pulverization. The moisture content of raw starch during heating should be about 50% or more based on the dry weight of raw starch. The lower the temperature, the higher the temperature. Therefore, it is preferable to perform the heat treatment in a paste-like or slurry-like state with a water content of 100% or more, since this is advantageous in terms of energy cost. Further, heating in this state is preferable because uniform heating can be applied to all particles. Regarding the heating temperature, it is difficult to specify because the gelatinization start temperature varies depending on the starch type, particle size, production area, refining conditions, water content of raw starch, etc., but in paste or slurry form, the starch type The gelatinization start temperature specific to
It is preferable to process at a temperature higher than 0°C but lower than that. By the way, "Starch Science Handbook" (supervised by Jiro Nikoku, published by Asakura Shoten)
1977, p. 36), the gelatinization initiation temperature of the main starches by the photopaste method is 66.8°C for corn;
, potato; 61.0℃, tapioca; 65.4℃, sweet potato;
The temperature is 65.8°C.

【0016】次に加熱方法であるが、澱粉を5〜50%
程度含む水懸濁液をつくった後、ジャケット付き攪拌槽
でジャケットに温水を通して昇温する方法、あるいは澱
粉懸濁液を攪拌しながら、直接温水を投入し昇温する方
法、あるいは温水の代わりに蒸気を吹き込む方法、ある
いは澱粉懸濁液をプレ−ト式熱交換機を通して加熱する
方法などがある。もっと澱粉の含有量を高めて、密閉状
態で高温加熱しても構わない。加熱時間は数10秒から
1時間程度まで自由に選び得るが、ペースト状あるいは
スラリー状で、糊化開始温度を10℃近く上回った温度
で長時間加熱すると、糊化が進みすぎ澱粉の粒子形態が
破壊され、冷水可溶分が増加するので好ましくない。所
定の加熱が終わった後は、糊化開始温度以下に冷却する
工程を加える方が品質が一定するので、好ましい。加熱
前あるいは加熱中あるいは加熱後に、可溶性澱粉、デキ
ストリン、アルファー化澱粉を、澱粉中の冷水可溶分が
10%を越えないように添加するのは構わない。また、
加熱中あるいは加熱後に、澱粉中の冷水可溶分が10%
を越えない程度に、攪拌、磨砕などを加えることも構わ
ない。次に乾燥方法であるが、ペースト状あるいはスラ
リー状のものを瞬時に乾燥可能な噴霧乾燥機、フラッシ
ュドライヤーなどが最適である。固形分濃度が高い場合
には、水を添加してから上記方法で乾燥してもよいが、
糊化開始温度より低い温度でそのまま乾燥することも可
能である。
Next, regarding the heating method, starch is added to 5 to 50%.
After making an aqueous suspension containing starch, the temperature is increased by passing hot water through the jacket in a jacketed stirring tank, or by directly adding hot water to the starch suspension while stirring, or instead of hot water. Methods include blowing steam or heating the starch suspension through a plate heat exchanger. You can also increase the starch content and heat it in a sealed state at a high temperature. The heating time can be freely selected from several tens of seconds to about an hour, but if the paste or slurry is heated for a long time at a temperature nearly 10°C above the gelatinization start temperature, gelatinization will progress too much and the starch particle morphology will change. is destroyed and the amount of cold water soluble content increases, which is undesirable. After the predetermined heating is completed, it is preferable to add a step of cooling to a temperature below the gelatinization start temperature because the quality becomes constant. Before, during, or after heating, soluble starch, dextrin, and pregelatinized starch may be added so that the cold water soluble content of the starch does not exceed 10%. Also,
During or after heating, the cold water soluble content of starch is 10%.
It is also possible to add stirring, grinding, etc. to an extent that does not exceed . Next, regarding the drying method, spray dryers, flash dryers, etc., which can instantly dry paste or slurry materials, are most suitable. If the solid content concentration is high, water may be added and then dried using the above method, but
It is also possible to directly dry it at a temperature lower than the gelatinization start temperature.

【0017】本発明の加工澱粉の原料となる生澱粉につ
いて述べる。生澱粉としては、コーン、小麦、米などの
地上澱粉、ポテト、タピオカ、甘藷などの地下茎澱粉な
どがあげられるが、いずれも使用し得る。また、2つ以
上の生澱粉の混合物を用いても構わない。地下茎澱粉は
温度によって糊化の程度が大きく変化するので、条件を
厳密にコントロール、例えば所定の温度に達したら即座
に冷却することによって糊化度をコントロールすれば使
用可能である。他には、例えばプレート式熱交を使用す
る方法を用いれば製造は容易である。
[0017] The raw starch that is the raw material for the processed starch of the present invention will be described. Examples of raw starches include terrestrial starches such as corn, wheat, and rice, and rhizome starches such as potato, tapioca, and sweet potato, and any of these may be used. Also, a mixture of two or more raw starches may be used. Since the degree of gelatinization of rhizome starch varies greatly depending on the temperature, it can be used if the conditions are strictly controlled, for example, by cooling immediately after reaching a predetermined temperature. In addition, manufacturing is easy if, for example, a method using a plate heat exchanger is used.

【0018】次に本発明の加工澱粉を用いた製剤組成物
について述べる。本発明の製剤組成物は、錠剤、顆粒剤
あるいは顆粒を充填したカプセル剤である。従来の加工
澱粉を使用した場合と比べて、錠剤(顆粒)硬度、崩壊
時間(ひいては薬物の溶出速度)共に優れた錠剤、顆粒
剤、カプセル剤となる。また、結晶セルロースや乳糖を
配合すると安定性の悪い薬物の場合に、加工澱粉を使用
すると安定性の良い製剤となる。また、ここでいう製剤
には、下記方法で作られる錠菓、機能性食品などの錠剤
、顆粒剤、カプセル剤の形状をした食品類も含まれると
考えるべきである。加工澱粉の添加量は、薬物の配合量
、製剤の大きさにより影響されるが、結合性と崩壊性の
両機能を満足するには2〜70%程度である。好ましく
は5〜50%程度である。また、他の添加剤としては、
結晶セルロース、乳糖、コーンスターチなど通常用いら
れる添加剤が配合できる。
Next, a pharmaceutical composition using the processed starch of the present invention will be described. The pharmaceutical composition of the present invention is a tablet, granule, or capsule filled with granules. This results in tablets, granules, and capsules that are superior in tablet (granule) hardness and disintegration time (as a result, drug dissolution rate) compared to cases where conventional processed starch is used. In addition, in the case of a drug that would be unstable if crystalline cellulose or lactose were added, a drug with good stability can be obtained by using modified starch. Furthermore, the term "preparation" as used herein should also be considered to include food products in the form of tablets, granules, and capsules, such as tablet confections and functional foods, which are made by the method described below. The amount of processed starch added is influenced by the amount of drug compounded and the size of the preparation, but is approximately 2 to 70% to satisfy both binding and disintegrating functions. Preferably it is about 5 to 50%. In addition, other additives include
Commonly used additives such as crystalline cellulose, lactose, and cornstarch can be added.

【0019】次に製剤組成物の製法について述べる。ま
ず、錠剤についてであるが、一種以上の薬物、加工澱粉
および必要であれば他の添加剤から成る粉体を混合し、
そのまま圧縮する、いわゆる直接打錠法あるいは上記粉
体を板状あるいは錠剤状に圧縮した後解砕し、顆粒を作
成し、さらに顆粒を圧縮する乾式顆粒圧縮法があげられ
る。顆粒剤は、上記方法で顆粒を作り、必要ならば篩分
する方法により作られる。カプセル剤は、上記顆粒をカ
プセルに充填して作られる。また、錠剤、顆粒をフィル
ムコーティングしたり糖衣掛けするのは自由である。
Next, the method for producing the pharmaceutical composition will be described. First, regarding tablets, a powder consisting of one or more drugs, modified starch, and other additives if necessary is mixed,
Examples include the so-called direct compression method, in which the powder is compressed as it is, and the dry granule compression method, in which the powder is compressed into a plate or tablet shape, then crushed to form granules, and the granules are further compressed. Granules are made by making granules by the above method and sieving if necessary. Capsules are made by filling capsules with the above granules. Furthermore, tablets and granules may be coated with a film or coated with sugar.

【0020】[0020]

【実施例】以下、実施例により本発明を説明する。なお
、加工澱粉と錠剤の物性評価方法は下記の通りである。 加工澱粉 ・含水率(%) 試料10gを105℃で6時間乾燥した時の減量を10
で除し、求める。
[Examples] The present invention will be explained below with reference to Examples. The method for evaluating the physical properties of processed starch and tablets is as follows. Modified starch/moisture content (%) The weight loss when drying 10g of sample at 105℃ for 6 hours is 10
Divide by and find.

【0021】・冷水可溶分(%) 25℃の純水297mlに試料3g(乾燥物換算)を加
え、エースホモジナイザー(日本精機(株)製)を用い
、1500rpmで2分間攪拌する。次に得られた懸濁
液を濾紙を用いて濾過する。濾液30mlを取り、10
5℃で恒量になるまで乾燥する。乾燥物重量を1000
倍し、用いた試料重量で除した値を冷水可溶分とする。
- Cold water soluble content (%) Add 3 g (in terms of dry matter) of the sample to 297 ml of pure water at 25°C, and stir for 2 minutes at 1500 rpm using an Ace homogenizer (manufactured by Nippon Seiki Co., Ltd.). The resulting suspension is then filtered using filter paper. Take 30ml of filtrate and
Dry at 5°C until constant weight. dry weight to 1000
Multiply the amount and divide by the weight of the sample used to determine the cold water soluble content.

【0022】・膨潤容積(ml/g) 25℃の純水約80gに、試料5gを加え分散させる。 分散液を共栓付き100mlメスシリンダーに入れ、純
水を加え100mlとする。密栓し24時間静置後、膨
潤した試料容積を5で除し膨潤容積とする。 ・嵩密度(g/ml) 100mlメスシリンダーに試料30gを少しずつ流し
込んだ時の試料の容積を測定する。30gを試料容積で
除し嵩密度とする。
- Swelling volume (ml/g) Add 5 g of sample to approximately 80 g of pure water at 25°C and disperse. Pour the dispersion into a 100 ml graduated cylinder with a stopper, and add pure water to make 100 ml. After sealing the container and leaving it for 24 hours, divide the swollen sample volume by 5 to obtain the swollen volume. - Bulk density (g/ml) Measure the volume of the sample when 30 g of the sample is poured little by little into a 100 ml measuring cylinder. Divide 30g by the sample volume to obtain the bulk density.

【0023】・100メッシュ留分(%)柳本製作所(
株)製ロータップ式篩分機により、100メッシュ篩(
目開き150μm)を装着し、試料30gを30分間篩
分した後の篩上の残留分である。 錠剤 ・硬度(kg) フロイント産業(株)製シュロインガー硬度計で錠剤の
径方向に力を加え、破壊したときの力で表す。繰り返し
数は20で、その平均値をとる。
・100 mesh fraction (%) Yanagimoto Seisakusho (
A 100 mesh sieve (
This is the residue on the sieve after 30 g of sample was sieved for 30 minutes using a sieve (opening 150 μm). Tablet/Hardness (kg) It is expressed as the force when the tablet is broken by applying force in the radial direction using a Schroinger hardness tester manufactured by Freund Sangyo Co., Ltd. The number of repetitions is 20, and the average value is taken.

【0024】・崩壊時間(分) 富山産業(株)製崩壊試験機NT−2HSで、崩壊液と
して純水を用いて行った。繰り返し数は6で、その平均
値をとる。なおディスクは使用していない。
- Disintegration time (minutes) The disintegration test was carried out using a disintegration tester NT-2HS manufactured by Toyama Sangyo Co., Ltd. using pure water as a disintegration liquid. The number of repetitions is 6, and the average value is taken. Note that the disc is not used.

【0025】[0025]

【実施例1】コ−ンスタ−チ(日澱化学(株)製)1k
gを60℃の温水7kgに分散させ、このスラリ−を攪
拌しながら、1℃/minの速度で昇温し、68℃にな
るまで加温した後、約20℃の水2kgを加え、熱処理
を止めた。次いで、小型噴霧乾燥機(大川原化工機(株
)製)を用いて、入口温度約160℃、スラリ−供給速
度7kg/hrの条件でスラリ−を噴霧して、加工澱粉
(A)を得た。加工澱粉(A)の物性を表1に示す。
[Example 1] Cornstarch (manufactured by Nippon Deka Chemical Co., Ltd.) 1k
g was dispersed in 7 kg of warm water at 60°C, and while stirring this slurry, the temperature was raised at a rate of 1°C/min until it reached 68°C, then 2 kg of water at about 20°C was added, and heat treatment was carried out. stopped. Next, the slurry was sprayed using a small spray dryer (manufactured by Okawara Kakoki Co., Ltd.) at an inlet temperature of about 160°C and a slurry supply rate of 7 kg/hr to obtain modified starch (A). . Table 1 shows the physical properties of processed starch (A).

【0026】[0026]

【実施例2】噴霧乾燥機の入口温度が約130℃である
こと以外は実施例1と同様に操作し、加工澱粉(B)を
得た。加工澱粉(B)の物性を表1に示す。
Example 2 Processed starch (B) was obtained in the same manner as in Example 1 except that the inlet temperature of the spray dryer was about 130°C. Table 1 shows the physical properties of the processed starch (B).

【0027】[0027]

【比較例1】特公昭59−47600号公報に準じた方
法で行った。コ−ンスタ−チ(日澱化学(株)製)1k
gを60℃の温水7kgに分散させ、このスラリ−を攪
拌しながら、1℃/minの速度で昇温し、65℃とし
た後、20分間加温した。次いで、入口温度を約180
℃とする以外は実施例と同様に操作し、加工澱粉(C)
を得た。加工澱粉(C)の物性を表1に示す。
[Comparative Example 1] The method was carried out in accordance with Japanese Patent Publication No. 59-47600. Cornstarch (manufactured by Nippon Star Chemical Co., Ltd.) 1k
g was dispersed in 7 kg of 60°C warm water, and while stirring this slurry, the temperature was raised at a rate of 1°C/min to 65°C, and then heated for 20 minutes. Then, the inlet temperature is set to about 180
Processed starch (C) was prepared in the same manner as in Example except that the temperature was
I got it. Table 1 shows the physical properties of processed starch (C).

【0028】[0028]

【比較例2】噴霧乾燥機の入口温度が約115℃である
こと以外は実施例1と同様に操作し、加工澱粉(D)を
得た。加工澱粉(D)の物性を表1に示す。
[Comparative Example 2] Processed starch (D) was obtained in the same manner as in Example 1 except that the inlet temperature of the spray dryer was about 115°C. Table 1 shows the physical properties of modified starch (D).

【0029】[0029]

【実施例3】加工澱粉(C)を25℃、75%RHの雰
囲気下にそれぞれ12時間、24時間放置し、加工澱粉
(E)、(F)を得た。加工澱粉(E)、(F)の物性
を表1に示す。
[Example 3] Processed starch (C) was left in an atmosphere of 25°C and 75% RH for 12 hours and 24 hours, respectively, to obtain processed starches (E) and (F). Table 1 shows the physical properties of processed starches (E) and (F).

【0030】[0030]

【比較例3】加工澱粉(C)を実施例3の条件で72時
間放置し、加工澱粉(G)を得た。加工澱粉(G)の物
性を表1に示す。
[Comparative Example 3] Processed starch (C) was left to stand under the conditions of Example 3 for 72 hours to obtain processed starch (G). Table 1 shows the physical properties of modified starch (G).

【0031】[0031]

【実施例4】65℃になるまで加温すること、噴霧乾燥
機の入口温度を約150℃にすること以外は実施例1と
同様に操作し、加工澱粉(H)を得た。加工澱粉(H)
の物性を表1に示す。
[Example 4] Processed starch (H) was obtained in the same manner as in Example 1, except that the temperature was heated to 65°C and the inlet temperature of the spray dryer was set to about 150°C. Processed starch (H)
The physical properties of are shown in Table 1.

【0032】[0032]

【実施例5】72℃になるまで加温すること以外は実施
例4と同様に操作し、加工澱粉(I)を得た。加工澱粉
(I)の物性を表1に示す。
[Example 5] Processed starch (I) was obtained in the same manner as in Example 4 except that the mixture was heated to 72°C. Table 1 shows the physical properties of modified starch (I).

【0033】[0033]

【比較例4】63℃になるまで加温すること以外は実施
例4と同様に操作し、加工澱粉(J)を得た。加工澱粉
(J)の物性を表1に示す。
[Comparative Example 4] Processed starch (J) was obtained in the same manner as in Example 4 except for heating to 63°C. Table 1 shows the physical properties of modified starch (J).

【0034】[0034]

【比較例5】80℃になるまで加温し、1時間保温する
こと以外は実施例4と同様に操作し、加工澱粉(K)を
得た。加工澱粉(K)の物性を表1に示す。
[Comparative Example 5] Processed starch (K) was obtained in the same manner as in Example 4 except that it was heated to 80°C and kept warm for 1 hour. Table 1 shows the physical properties of processed starch (K).

【0035】[0035]

【実施例6】フェナセチン(山本化学(株)製、微粉)
200部、結晶セルロ−ス(旭化成工業(株)製、アビ
セルPH−101)400部、乳糖(DMV社製、10
0メッシュ)295部、ステアリン酸マグネシウム(太
平化学(株)製)5部に加工澱粉(A)100部を配合
し、常法どおり混合した後、ロ−タリ−打錠機(菊水製
作所(株)製、コレクト12)を用いて、錠剤径8mm
φ、平均錠剤重量200mgの錠剤を得た。錠剤物性を
表2に示す。
[Example 6] Phenacetin (manufactured by Yamamoto Chemical Co., Ltd., fine powder)
200 parts, crystalline cellulose (manufactured by Asahi Kasei Corporation, Avicel PH-101), 400 parts, lactose (manufactured by DMV, 10
0 mesh), 5 parts of magnesium stearate (manufactured by Taihei Kagaku Co., Ltd.) and 100 parts of modified starch (A) were mixed in a conventional manner. ), using Collect 12), tablet diameter 8 mm
Tablets with an average tablet weight of 200 mg were obtained. Tablet physical properties are shown in Table 2.

【0036】[0036]

【実施例7】加工澱粉(B)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
[Example 7] The same procedure as in Example 6 was carried out except that modified starch (B) was used. Tablet physical properties are shown in Table 2.

【0037】[0037]

【実施例8】加工澱粉(E)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
[Example 8] The procedure of Example 6 was repeated except that modified starch (E) was used. Tablet physical properties are shown in Table 2.

【0038】[0038]

【実施例9】加工澱粉(F)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
[Example 9] The same procedure as in Example 6 was carried out except that modified starch (F) was used. Tablet physical properties are shown in Table 2.

【0039】[0039]

【実施例10】加工澱粉(H)を用いる以外は実施例6
と同様に操作した。錠剤物性を表2に示す。
[Example 10] Example 6 except for using modified starch (H)
operated in the same way. Tablet physical properties are shown in Table 2.

【0040】[0040]

【実施例11】加工澱粉(I)を用いる以外は実施例6
と同様に操作した。錠剤物性を表2に示す。
[Example 11] Example 6 except for using modified starch (I)
operated in the same way. Tablet physical properties are shown in Table 2.

【0041】[0041]

【比較例6】加工澱粉(C)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
[Comparative Example 6] The same procedure as in Example 6 was carried out except that modified starch (C) was used. Tablet physical properties are shown in Table 2.

【0042】[0042]

【比較例7】加工澱粉(D)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
[Comparative Example 7] The same procedure as in Example 6 was carried out except that modified starch (D) was used. Tablet physical properties are shown in Table 2.

【0043】[0043]

【比較例8】加工澱粉(G)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
[Comparative Example 8] The same procedure as in Example 6 was carried out except that modified starch (G) was used. Tablet physical properties are shown in Table 2.

【0044】[0044]

【比較例9】加工澱粉(J)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
[Comparative Example 9] The same procedure as in Example 6 was carried out except that modified starch (J) was used. Tablet physical properties are shown in Table 2.

【0045】[0045]

【比較例10】加工澱粉(K)を用いる以外は実施例6
と同様に操作した。錠剤物性を表2に示す。
[Comparative Example 10] Example 6 except for using modified starch (K)
operated in the same way. Tablet physical properties are shown in Table 2.

【0046】[0046]

【比較例11】加工澱粉のかわりにコーンスターチ(C
S、日澱化学(株)製)を用い、実施例6と同様に打錠
する。CSの物性を表1に示し、打錠結果を表2に示す
[Comparative Example 11] Corn starch (C
S, manufactured by Nippon Deka Chemical Co., Ltd.) in the same manner as in Example 6. Table 1 shows the physical properties of CS, and Table 2 shows the tableting results.

【0047】[0047]

【実施例12】コ−ンスタ−チ1.5kgを60℃の温
水4kgに分散させた後、67℃に昇温する。次いでこ
れをトレイに移し、40℃の熱風乾燥機で水分約12%
になるまで乾燥した後、バンタムミル(ホソカワミクロ
ン社製)で粉砕して、加工澱粉(L)を得た。加工澱粉
(L)の物性を表3に示す。
[Example 12] 1.5 kg of cornstarch is dispersed in 4 kg of 60°C hot water, and then the temperature is raised to 67°C. Next, transfer this to a tray and use a hot air dryer at 40℃ to reduce the moisture content to about 12%.
After drying until dry, the starch was ground with a bantam mill (manufactured by Hosokawa Micron) to obtain processed starch (L). Table 3 shows the physical properties of the processed starch (L).

【0048】[0048]

【比較例12】水分約7%になるまで乾燥する以外は、
実施例12と同様に操作し、加工澱粉(M)を得た。加
工澱粉(M)の物性を表3に示す。
[Comparative Example 12] Except for drying until the moisture content is about 7%,
The same procedure as in Example 12 was carried out to obtain processed starch (M). Table 3 shows the physical properties of the modified starch (M).

【0049】[0049]

【実施例13】噴霧乾燥を行う前に、バッチ式アトライ
タ10S(三井三池化工機(株)、3mmφのアルミナ
ボ−ル使用)を用いて、500rpmで5分間処理する
以外は、実施例4と同様に操作し、加工澱粉(N)を得
た。加工澱粉(N)の物性を表3に示す。
[Example 13] Same as Example 4, except that before spray drying, treatment was performed at 500 rpm for 5 minutes using a batch type attritor 10S (Mitsui Miike Kakoki Co., Ltd., using alumina balls of 3 mm diameter). Processed starch (N) was obtained. Table 3 shows the physical properties of processed starch (N).

【0050】[0050]

【実施例14】バッチ式アトライタ10Sで、20分間
処理する以外は、実施例13と同様に操作し、加工澱粉
(O)を得た。加工澱粉(O)の物性を表3に示す。
[Example 14] Processed starch (O) was obtained in the same manner as in Example 13, except that it was processed for 20 minutes using a batch type attritor 10S. Table 3 shows the physical properties of modified starch (O).

【0051】[0051]

【比較例13】バッチ式アトライタ10Sで、40分間
処理する以外は、実施例13と同様に操作し、加工澱粉
(P)を得た。加工澱粉(P)の物性を表3に示す。
Comparative Example 13 Processed starch (P) was obtained in the same manner as in Example 13, except that it was treated for 40 minutes using a batch type attritor 10S. Table 3 shows the physical properties of processed starch (P).

【0052】[0052]

【比較例14】噴霧乾燥を行う前に、バッチ式アトライ
タ10S(3mmφのアルミナボールを使用)を用いて
、500rpmで2分間処理する以外は、比較例1と同
様に操作し、加工澱粉(Q)を得た。加工澱粉(Q)の
物性を表3に示す。
[Comparative Example 14] Processed starch (Q ) was obtained. Table 3 shows the physical properties of modified starch (Q).

【0053】[0053]

【実施例15】ポテトスタ−チ(日澱化学(株)製)を
用い、到達温度を62℃とする以外は実施例2と同様に
行い、加工澱粉(R)を得た。加工澱粉(R)の物性を
表3に示す。
[Example 15] Processed starch (R) was obtained in the same manner as in Example 2 except that potato starch (manufactured by Nippon Star Chemical Co., Ltd.) was used and the temperature reached was 62°C. Table 3 shows the physical properties of modified starch (R).

【0054】[0054]

【実施例16】噴霧乾燥を行う前に、デキストリン(松
谷化学(株)製、パインデックス−100)をコ−ンス
タ−チ固形分に対して3%添加する以外は、実施例2と
同様に行い、加工澱粉(S)を得た。加工澱粉(S)の
物性を表3に示す。
[Example 16] The same procedure as in Example 2 was carried out, except that dextrin (manufactured by Matsutani Chemical Co., Ltd., Pine Index-100) was added in an amount of 3% based on the solid content of corn starch before spray drying. Processed starch (S) was obtained. Table 3 shows the physical properties of processed starch (S).

【0055】[0055]

【比較例15】特公昭46−21472号公報の技術3
に準じた方法で行った。即ち、コーンスターチに加水し
、水分含量25%とした後、ロールミル(ノリタケカン
パニー製、NR−42A)を3回磨砕し、熱風乾燥機で
60℃で水分8%になるまで乾燥した。次いで、バンタ
ムミルで粉砕した後、含水率12%まで加湿させ、加工
澱粉(T)を得た。加工澱粉(T)の物性を表3に示す
[Comparative Example 15] Technology 3 of Japanese Patent Publication No. 46-21472
It was carried out in accordance with the method. That is, after adding water to cornstarch to make the water content 25%, it was ground three times using a roll mill (NR-42A, manufactured by Noritake Company), and dried at 60° C. in a hot air dryer until the water content was 8%. Next, after pulverizing with a bantam mill, the starch was humidified to a moisture content of 12% to obtain processed starch (T). Table 3 shows the physical properties of processed starch (T).

【0056】[0056]

【比較例16】特開昭60−233019号公報の例2
に準じた方法で行った。即ち、コーンスターチ1kgを
水1.5kgに分散させ、2.5gの塩化カルシウム加
える。希水酸化ナトリウム溶液を加えることで、pHを
6.0〜6.5に調製する。4%α−アミラーゼ(関東
化学(株)製)溶液250mlを加えた後、55℃に昇
温し、4時間反応させる。次いで希塩酸でpHを2〜3
にし、15分間保った後再び希水酸化ナトリウムを添加
し、pHを約6とする。残渣を濾過洗浄した後、熱風乾
燥機で乾燥し、バンタムミルで粉砕し、加工澱粉(U)
を得た。加工澱粉(U)の物性を表3に示す。
[Comparative Example 16] Example 2 of JP-A-60-233019
It was carried out in accordance with the method. That is, 1 kg of corn starch is dispersed in 1.5 kg of water, and 2.5 g of calcium chloride is added. Adjust the pH to 6.0-6.5 by adding dilute sodium hydroxide solution. After adding 250 ml of 4% α-amylase (manufactured by Kanto Kagaku Co., Ltd.) solution, the temperature was raised to 55° C. and reacted for 4 hours. Then adjust the pH to 2-3 with dilute hydrochloric acid.
After holding for 15 minutes, dilute sodium hydroxide is added again to bring the pH to about 6. After filtering and washing the residue, it is dried with a hot air dryer and ground with a bantam mill to obtain processed starch (U).
I got it. Table 3 shows the physical properties of the processed starch (U).

【0057】[0057]

【比較例17】市販品スターチ1500(日本カラコン
(株)製)を加工澱粉(V)とする。加工澱粉(V)の
物性を表3に示す。
[Comparative Example 17] Commercially available starch 1500 (manufactured by Nippon Colorcon Co., Ltd.) was used as modified starch (V). Table 3 shows the physical properties of modified starch (V).

【0058】[0058]

【比較例18】市販品PCS(旭化成工業(株)製)を
加工澱粉(W)とする。加工澱粉(W)の物性を表3に
示す。
[Comparative Example 18] Commercial product PCS (manufactured by Asahi Kasei Industries, Ltd.) was used as modified starch (W). Table 3 shows the physical properties of processed starch (W).

【0059】[0059]

【実施例17】L−アスコルビン酸(武田薬品工業(株
)製)495gと加工澱粉(L)500部を混合し、次
いでステアリン酸マグネシウム5部を混合し、実施例6
と同様に打錠し、錠剤を得た。錠剤物性を表4に示す。
[Example 17] 495 g of L-ascorbic acid (manufactured by Takeda Pharmaceutical Co., Ltd.) and 500 parts of modified starch (L) were mixed, and then 5 parts of magnesium stearate were mixed.
The mixture was compressed in the same manner as above to obtain tablets. Tablet physical properties are shown in Table 4.

【0060】[0060]

【実施例18】加工澱粉(N)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Example 18] Example 1 except for using modified starch (N)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0061】[0061]

【実施例19】加工澱粉(O)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Example 19] Example 1 except for using modified starch (O)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0062】[0062]

【実施例20】加工澱粉(R)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Example 20] Example 1 except for using modified starch (R)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0063】[0063]

【実施例21】加工澱粉(S)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Example 21] Example 1 except for using modified starch (S)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0064】[0064]

【比較例19】加工澱粉(M)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Comparative Example 19] Example 1 except for using modified starch (M)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0065】[0065]

【比較例20】加工澱粉(P)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Comparative Example 20] Example 1 except for using modified starch (P)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0066】[0066]

【比較例21】加工澱粉(Q)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Comparative Example 21] Example 1 except for using modified starch (Q)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0067】[0067]

【比較例22】加工澱粉(T)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Comparative Example 22] Example 1 except for using modified starch (T)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0068】[0068]

【比較例23】加工澱粉(U)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Comparative Example 23] Example 1 except for using modified starch (U)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0069】[0069]

【比較例24】加工澱粉(V)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Comparative Example 24] Example 1 except for using modified starch (V)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0070】[0070]

【比較例25】加工澱粉(W)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
[Comparative Example 25] Example 1 except for using modified starch (W)
It was operated in the same manner as in 7. Tablet physical properties are shown in Table 4.

【0071】[0071]

【実施例22】加工澱粉(B)400g、アスピリン(
保栄薬工(株)製)400g、200メッシュ乳糖(D
MV社製)190gを混合し、さらにステアリン酸マグ
ネシウム10gを加えて混合する。次に、混合した粉体
をローラーコンパクター・ミニ(フロイント産業(株)
製)を用いて、2トンの圧力で板上に圧縮した後、解砕
した。次いで、解砕物を篩分して、12メッシュ(目開
き1410μm)を通過し、80メッシュ(目開き18
0μm)に残留する顆粒を、ロータリー打錠機を用いて
実施例6と同様に打錠し、錠剤を得た。錠剤物性を表5
に示す。
[Example 22] 400g of modified starch (B), aspirin (
Hoei Yakuko Co., Ltd.) 400g, 200 mesh lactose (D
(manufactured by MV) were mixed, and 10 g of magnesium stearate was further added and mixed. Next, the mixed powder was processed using a roller compactor mini (Freund Sangyo Co., Ltd.).
After compressing it onto a plate under a pressure of 2 tons, it was crushed. Next, the crushed material was sieved to pass through a 12 mesh (opening 1410 μm), and then through an 80 mesh (opening 18
The remaining granules (0 μm) were compressed using a rotary tablet machine in the same manner as in Example 6 to obtain tablets. Table 5 Tablet physical properties
Shown below.

【0072】[0072]

【実施例23】加工澱粉(N)を用いる以外は実施例2
2と同様に操作した。錠剤物性を表5に示す。
[Example 23] Example 2 except for using modified starch (N)
The procedure was the same as in 2. Table 5 shows the physical properties of the tablet.

【0073】[0073]

【比較例26】加工澱粉(C)を用いる以外は実施例2
2と同様に操作した。錠剤物性を表5に示す。
[Comparative Example 26] Example 2 except for using modified starch (C)
The procedure was the same as in 2. Table 5 shows the physical properties of the tablet.

【0074】[0074]

【比較例27】加工澱粉(T)を用いる以外は実施例2
2と同様に操作した。錠剤物性を表5に示す。
[Comparative Example 27] Example 2 except using modified starch (T)
The procedure was the same as in 2. Table 5 shows the physical properties of the tablet.

【0075】[0075]

【比較例28】加工澱粉(U)を用いる以外は実施例2
2と同様に操作した。錠剤物性を表5に示す。
[Comparative Example 28] Example 2 except using modified starch (U)
The procedure was the same as in 2. Table 5 shows the physical properties of the tablet.

【0076】[0076]

【表1】[Table 1]

【0077】[0077]

【表2】[Table 2]

【0078】[0078]

【表3】[Table 3]

【0079】[0079]

【表4】[Table 4]

【0080】[0080]

【表5】[Table 5]

【0081】[0081]

【発明の効果】特定された物性を持つことにより、結合
性と崩壊性の両機能を同時に併せ持つ加工澱粉を用いて
、直接打錠あるいは乾式顆粒法で製剤すると、結合性に
優れるため、錠剤硬度あるいは顆粒強度の高い製剤がで
きる。また、同時に崩壊性にも優れるので、その製剤は
投与後、迅速な崩壊を示し、薬物の溶出速度が早くなる
。以上、加工澱粉が結合性と崩壊性の両機能を持つため
、処方を簡潔にできること、薬物に対する安定性が高い
ことなどにより、品質設計が容易になる。
[Effect of the invention] When a processed starch with specified physical properties that has both binding and disintegrating functions is used to formulate tablets by direct compression or dry granulation, it has excellent binding properties, resulting in tablet hardness. Alternatively, preparations with high granule strength can be made. Furthermore, since it has excellent disintegration properties, the preparation disintegrates quickly after administration, resulting in a rapid dissolution rate of the drug. As mentioned above, since modified starch has both binding and disintegrating functions, it can be formulated simply and has high stability against drugs, which facilitates quality design.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】生澱粉を水分の存在下、加熱処理すること
により得られる加工澱粉であって、含水率が8〜15%
、冷水可溶分が10%未満、膨潤容積が5〜15ml/
gである結合性、崩壊性に優れる加工澱粉。
Claim 1: Processed starch obtained by heat-treating raw starch in the presence of moisture, with a moisture content of 8 to 15%.
, cold water soluble content is less than 10%, swelling volume is 5-15ml/
A processed starch with excellent binding and disintegrating properties.
【請求項2】請求項1である加工澱粉を含有することを
特徴とする製剤組成物。
2. A pharmaceutical composition comprising the modified starch according to claim 1.
JP3085426A 1991-04-17 1991-04-17 Processed starch with excellent binding and disintegration properties Expired - Lifetime JP3004758B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3085426A JP3004758B2 (en) 1991-04-17 1991-04-17 Processed starch with excellent binding and disintegration properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3085426A JP3004758B2 (en) 1991-04-17 1991-04-17 Processed starch with excellent binding and disintegration properties

Publications (2)

Publication Number Publication Date
JPH04318001A true JPH04318001A (en) 1992-11-09
JP3004758B2 JP3004758B2 (en) 2000-01-31

Family

ID=13858507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3085426A Expired - Lifetime JP3004758B2 (en) 1991-04-17 1991-04-17 Processed starch with excellent binding and disintegration properties

Country Status (1)

Country Link
JP (1) JP3004758B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001039894A (en) * 1999-06-26 2001-02-13 Cerestar Holding Bv Binder for compression tablet and direct compression starch as an enhancer for vehicle in the case where it is used as a disintegrator
WO2005005484A1 (en) * 2003-07-11 2005-01-20 Asahi Kasei Chemicals Corporation Functional starch powder
JP2006045222A (en) * 2004-07-09 2006-02-16 Natl Starch & Chem Investment Holding Corp Tablet excipient
JP2006143650A (en) * 2004-11-19 2006-06-08 Asahi Kasei Chemicals Corp Method for producing tablet containing medicine having high adhesiveness
JP2007001999A (en) * 2005-06-21 2007-01-11 Asahi Kasei Chemicals Corp Method for producing granule composition
WO2008032767A1 (en) * 2006-09-14 2008-03-20 Astellas Pharma Inc. Orally disintegrating tablet and process for production thereof
WO2009123102A1 (en) * 2008-03-31 2009-10-08 旭化成ケミカルズ株式会社 Processed starch powder with excellent disintegration properties and manufacturing method thereof
JP2010521416A (en) * 2007-03-13 2010-06-24 武田薬品工業株式会社 2-[[6-[(3R) -3-Amino-1-piperidinyl] -3,4-dihydro-3-methyl-2,4-dioxo-1 (2H) -pyrimidinyl] methyl] -4-fluorobenzo Solid formulation containing nitrile
US9029427B2 (en) 2005-11-11 2015-05-12 Asahi Kasei Chemicals Corporation Controlled release solid preparation
JP2015218322A (en) * 2014-05-21 2015-12-07 旭化成ケミカルズ株式会社 Fine starch particle and production method thereof

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001039894A (en) * 1999-06-26 2001-02-13 Cerestar Holding Bv Binder for compression tablet and direct compression starch as an enhancer for vehicle in the case where it is used as a disintegrator
WO2005005484A1 (en) * 2003-07-11 2005-01-20 Asahi Kasei Chemicals Corporation Functional starch powder
JPWO2005005484A1 (en) * 2003-07-11 2006-10-26 旭化成ケミカルズ株式会社 Functional starch powder
US9101155B2 (en) 2003-07-11 2015-08-11 Asahi Kasei Chemicals Corporation Functional starch powder
JP4959191B2 (en) * 2003-07-11 2012-06-20 旭化成ケミカルズ株式会社 Functional starch powder
KR101303267B1 (en) * 2004-07-09 2013-09-03 콘 프로덕츠 디벨롭먼트, 인크. Tablet excipient
JP2006045222A (en) * 2004-07-09 2006-02-16 Natl Starch & Chem Investment Holding Corp Tablet excipient
JP2006143650A (en) * 2004-11-19 2006-06-08 Asahi Kasei Chemicals Corp Method for producing tablet containing medicine having high adhesiveness
JP2007001999A (en) * 2005-06-21 2007-01-11 Asahi Kasei Chemicals Corp Method for producing granule composition
US9029427B2 (en) 2005-11-11 2015-05-12 Asahi Kasei Chemicals Corporation Controlled release solid preparation
JP5332615B2 (en) * 2006-09-14 2013-11-06 アステラス製薬株式会社 Orally disintegrating tablet and method for producing the same
WO2008032767A1 (en) * 2006-09-14 2008-03-20 Astellas Pharma Inc. Orally disintegrating tablet and process for production thereof
JP2010521416A (en) * 2007-03-13 2010-06-24 武田薬品工業株式会社 2-[[6-[(3R) -3-Amino-1-piperidinyl] -3,4-dihydro-3-methyl-2,4-dioxo-1 (2H) -pyrimidinyl] methyl] -4-fluorobenzo Solid formulation containing nitrile
US8431618B2 (en) 2008-03-31 2013-04-30 Asahi Kasei Chemicals Corporation Processed starch powder with excellent disintegration properties and manufacturing method thereof
JP5577241B2 (en) * 2008-03-31 2014-08-20 旭化成ケミカルズ株式会社 Processed starch powder with excellent disintegration and process for producing the same
WO2009123102A1 (en) * 2008-03-31 2009-10-08 旭化成ケミカルズ株式会社 Processed starch powder with excellent disintegration properties and manufacturing method thereof
JP2015218322A (en) * 2014-05-21 2015-12-07 旭化成ケミカルズ株式会社 Fine starch particle and production method thereof

Also Published As

Publication number Publication date
JP3004758B2 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
KR960009182B1 (en) Pharmaceutical tablet and granulate and process for their preparation
CA1337399C (en) Ibuprofen taste-masking process
CA2414945C (en) Cellulose powder
KR860000530B1 (en) Starch
US5888548A (en) Spherically agglomerated starches with silicon dioxide
CN1823091B (en) Functional starch powder
JPS60233019A (en) Compressed starch as tablet or capsule binder
JPS5818322A (en) Tablet decomposing agent and manufacture
JP3534130B2 (en) Pharmaceutical composition
US5651988A (en) Combination osmotic and bulk forming laxatives
JPH04318001A (en) Processed starch excellent in bindability and disintegrability
JP3212534B2 (en) Low substituted hydroxypropylcellulose powder
JP3368898B1 (en) Process for producing granules containing branched chain amino acids
JP4306965B2 (en) Bulking and decomposing composition, method for achieving it and use thereof
WO2008059652A1 (en) Disintegrating agent, and tablet and granule each containing the same
JP4774739B2 (en) Kampo extract-containing tablet composition and method for producing the same
JP4947613B2 (en) Method for producing granulated composition
JP2001181195A (en) Solid preparation containing tetousutore extract as active ingredient
US20010003619A1 (en) Diluent and desintegrating composition, a process for the preparation thereof and the use thereof
JP780H (en) Processed starch
JPS59193815A (en) Preparation of tablet
Nwachukwu et al. Application of microcrystalline cellulose obtained from Gossypium herbaceum in direct compression of chlorpheniramine maleate tablets
WO1997031627A1 (en) Use of microcrystalline starch products as tabletting excipient
JPS62153222A (en) Production of chinese drug extract
JP2000239186A (en) Disintegrator for tablet

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19991102

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081119

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081119

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091119

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091119

Year of fee payment: 10

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091119

Year of fee payment: 10

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101119

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101119

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111119

Year of fee payment: 12

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111119

Year of fee payment: 12